Advertisement

Biomembranes pp 89-129 | Cite as

Cell Membrane Associated Antigens in Chemical Carcinogenesis

  • Robert W. Baldwin
  • Michael R. Price
Part of the Biomembranes book series (B, volume 8)

Abstract

One of the most intriguing facets of neoplastic transformation, whether induced by chemical carcinogens or oncogenic viruses, is the expression at the surface membrane of the transformed cell of neoantigens which are not expressed on their normal cell counterparts, at least in the adult host. However, it is now over two decades since the first acceptable report on tumor-associated rejection antigens on 3-methylcholanthrene-induced murine sarcomas (Foley, 1953), and yet only relatively recently have significant advances been made in the study of the chemistry and biology of these tumor cell components. This is due to some extent to an initial reluctance to accept that the immunity elicited against transplanted tumor cells in highly inbred (syngeneic) animals was a tumor-specific phenomenon and was not due to weak alloantigen responses. Furthermore, only relatively recently has it been possible to detect and measure in vitro cell-mediated and humoral tumor-immune responses.

Keywords

Bacillus Calmette Guerin Chemical Carcinogenesis Embryonic Antigen Murine Sarcoma Antigenic Fraction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abelev, G. I., 1974, α-Fetoprotein as a marker of embryo-specific differentiations in normal and tumor tissues, Transplant. Rev. 20:3.PubMedGoogle Scholar
  2. Abelev, G. I., Perova, S. D., Khramkova, N. I., Postnikova, Z. A., and Irlin, I. S., 1963, Production of embryonal α-globulin by transplantable mouse hepatomas, Transplantation 1:174.PubMedCrossRefGoogle Scholar
  3. Albright, N. L., and Myers, G. H., 1972, Specific antigens of a chemically induced tumor: Detection by complement fixation, J. Natl. Cancer Inst. 49:295.PubMedGoogle Scholar
  4. Apffel, C. A., Arnason, B. G., and Peters, J. H., 1966, Induction of tumor immunity with tumor cells treated with iodoacetate, Nature (London) 209:694.CrossRefGoogle Scholar
  5. Baldwin, R. W., 1955, Immunity to methylcholanthrene-induced tumours in inbred rats following atrophy and regression of implanted tumours, Br. J. Cancer 9:652.PubMedCrossRefGoogle Scholar
  6. Baldwin, R. W., 1973, Immunological aspects of chemical carcinogenesis, Advan. Cancer Res. 18:1.CrossRefGoogle Scholar
  7. Baldwin, R. W., and Barker, C. R., 1967a, Tumour-specific antigenicity of aminoazo-dye-induced rat hepatomas, Int. J. Cancer 2:355.PubMedCrossRefGoogle Scholar
  8. Baldwin, R. W., and Barker, C. R., 1967b, Demonstration of tumour-specific humoral antibody against aminoazo dye-induced rat hepatomata, Br. J. Cancer 21:793.PubMedCrossRefGoogle Scholar
  9. Baldwin, R. W., and Barker, C. R., 1967c, Antigenic composition of transplanted rat hepatomas originally induced by 4-dimethylaminoazobenzene, Br. J. Cancer 21:338.PubMedCrossRefGoogle Scholar
  10. Baldwin, R. W., and Embleton, M. J., 1969, Immunology of 2-acetylaminofluorene-induced rat mammary adenocarcinomas, Int. J. Cancer 4:47.PubMedCrossRefGoogle Scholar
  11. Baldwin, R. W., and Embleton, M. J., 1971a, Demonstration by colony inhibition methods of cellular and humoral immune reactions to tumour-specific antigens associated with aminoazo-dye-induced rat hepatomas, Int. J. Cancer 7:17.PubMedCrossRefGoogle Scholar
  12. Baldwin, R. W., and Embleton, M. J., 1971b, Tumor-specific antigens in 2-acetylamino-fluorene-induced rat hepatomas and related tumors, Israel J. Med. Sci. 7:144.PubMedGoogle Scholar
  13. Baldwin, R. W., and Embleton, M. J., 1974, Neoantigens on spontaneous and carcinogen-induced rat tumours defined by in vitro lymphocytotoxicity assays, Int. J. Cancer 13:433.PubMedCrossRefGoogle Scholar
  14. Baldwin, R. W., and Glaves, D., 1972, Solubilization of tumour-specific antigen from plasma membrane of an aminoazo-dye-induced rat hepatoma, Clin. Exp. Immunol. 11:51.PubMedGoogle Scholar
  15. Baldwin, R. W., and Moore, M., 1969, Isolation of membrane-associated tumour-specific antigen from an aminoazo-dye-induced rat hepatoma, Int. J. Cancer 4:753.PubMedCrossRefGoogle Scholar
  16. Baldwin, R. W., and Moore, M., 1971, Tumour-specific antigens and tumour-host interactions, in: Immunological Tolerance to Tissue Antigens (N. W. Nisbet and M. W. Elves, eds.), pp. 299–313, Orthopaedic Hospital, Oswestry, England.Google Scholar
  17. Baldwin, R. W., and Pimm, M. V., 1973, BCG immunotherapy of a rat sarcoma, Br. J. Cancer 28:281.PubMedCrossRefGoogle Scholar
  18. Baldwin, R. W., and Price, M. R., 1976, Immunology of experimental liver cancer, in: Liver Cell Cancer (H. M. Cameron, G. P. Warwick, and C. A. Linsell, eds.), Elsevier, Amsterdam.Google Scholar
  19. Baldwin, R. W., and Vose, B. M., 1974, Embryonic antigen expression on 2-acetylaminofluorene induced and spontaneously arising rat tumours, Br. J. Cancer 30:209.PubMedCrossRefGoogle Scholar
  20. Baldwin, R. W., and Vose, B. M., 1975, The expression of a phase specific foetal antigen on rat embryo cells, Transplantation 18:525.CrossRefGoogle Scholar
  21. Baldwin, R. W., Barker, C. R., Embleton, M. J., Glaves, D., Moore, M., and Pimm, M. V., 1971a, Demonstration of cell-surface antigens on chemically induced tumors, Ann. N.Y. Acad. Sci. 177:268.PubMedCrossRefGoogle Scholar
  22. Baldwin, R. W., Glaves, D., and Pimm, M. V., 1971b, Tumor-associated antigens as expressions of chemically-induced neoplasia and their involvement in tumor-host interactions, in: Progress in Immunology (B. Amos, ed.), pp. 907–920, Academic Press, New York.Google Scholar
  23. Baldwin, R. W., Glaves, D., Harris, J. R., and Price, M. R., 1971c, Tumor-specific antigens associated with aminoazo dye-induced rat hepatomas, Transplant. Proc. 3:1189.Google Scholar
  24. Baldwin, R. W., Glaves, D., Pimm, M. V., and Vose, B. M., 1972a, Tumour specific andGoogle Scholar
  25. embryonic antigen expression on chemically induced rat tumours, Ann. Inst. Pasteur 122:715.Google Scholar
  26. Baldwin, R. W., Harris, J. R., and Price, M. R., 1972b, Isolation of plasma-membrane-associated tumor-specific antigen from rat hepatoma cells, Biochem. J. 128:130.Google Scholar
  27. Baldwin, R. W., Glaves, D., and Vose, B. M., 1972c, Embryonic antigen expression in chemically induced rat hepatomas and sarcomas, Int. J. Cancer 10:233.PubMedCrossRefGoogle Scholar
  28. Baldwin, R. W., Price, M. R., and Robins, R. A., 1972d, Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes, Nature (London) New Biol. 238:185.CrossRefGoogle Scholar
  29. Baldwin, R. W., Embleton, M. J., and Robins, R. A., 1973a, Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status, Int. J. Cancer 11:1.PubMedCrossRefGoogle Scholar
  30. Baldwin, R. W., Harris, J. R., and Price, M. R., 1973b, Fractionation of plasma membrane-associated tumour specific antigen from an aminoazo dye-induced rat hepatoma, Int. J. Cancer 11:385.PubMedCrossRefGoogle Scholar
  31. Baldwin, R. W., Price, M. R., and Robins, R. A., 1973c, Characterization of serum factors blocking lymphocyte cytotoxicity for tumor cells, in: 26th M. D. Anderson Annual Symposium on Fundamental Cancer Research pp. 205–222. Williams and Wilkins, Baltimore.Google Scholar
  32. Baldwin, R. W., Price, M. R., and Robins, R. A., 1973d, Significance of serum factors modifying cellular immune responses to growing tumours, Br. J. Cancer 28:37 (Suppl. I).Google Scholar
  33. Baldwin, R. W., Price, M. R., and Robins, R. A., 1973e, Inhibition of hepatoma-immune lymph node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen, Int. J. Cancer 11:527.PubMedCrossRefGoogle Scholar
  34. Baldwin, R. W., Bowen, J. G., Embleton, M. J., Price, M. R., and Robins, R. A., 1974a, Cellular and humoral immune responses to neoantigens associated with chemically-induced tumours, in: Progress in Immunology II, Vol. 3 (L. Brent and J. Holborow, eds.), pp. 239–249, North-Holland, Amsterdam.Google Scholar
  35. Baldwin, R. W., Bowen, J. G., and Price, M. R., 1974b, Solubilization of membrane-associated tumour-specific antigens by β-glucosidase, Biochim. Biophys. Acta 367:47.PubMedCrossRefGoogle Scholar
  36. Baldwin, R. W., Embleton, M. J., Price, M. R., and Vose, B. M., 1974c, Embryonic antigen expression on experimental rat tumours, Transplant. Rev. 20:77.PubMedGoogle Scholar
  37. Baldwin, R. W., Glaves, D., and Vose, B. M., 1974d, Differentiation between the embryonic and tumour specific antigens on chemically induced rat tumours, Br. J. Cancer 29:1.PubMedCrossRefGoogle Scholar
  38. Baldwin, R. W., Glaves, D., and Vose, B. M., 1974e, Immunogenicity of embryonic antigens associated with chemically induced rat tumours, Int. J. Cancer 13:135.PubMedCrossRefGoogle Scholar
  39. Bansal, S. C., and Sjögren, H. O., 1971, “Unblocking” serum activity in vitro in the polyoma system may correlate with antitumor effects of antiserum in vivo, Nature (London) New Biol. 233:76.Google Scholar
  40. Bansal, S. C., and Sjögren, H. O., 1972, Counteraction of the blocking of cell-mediated tumor immunity by inoculation of unblocking sera and splenectomy: Immunothera-peutic effects on primary polyoma tumors in rats, Int. J. Cancer 9:490.PubMedCrossRefGoogle Scholar
  41. Bartlett, G. L., 1972, Effect of host immunity on the antigenic strength of primary tumors, J. Natl. Cancer Inst. 49:493.PubMedGoogle Scholar
  42. Bartlett, G. L., and Zbar, B., 1972, Tumor-specific vaccine containing Mycobacterium bovis and tumor cells: Safety and efficacy, J. Natl. Cancer Inst. 48:1709.PubMedGoogle Scholar
  43. Basombrío, M. A., 1970, Search for common antigenicities among twenty-five sarcomas induced by methylcholanthrene, Cancer Res. 30:2458.PubMedGoogle Scholar
  44. Basombrío, M. A., and Prehn, R. T., 1972a, Antigenic diversity of tumors chemically induced within the progeny of a single cell, Int. J. Cancer 10:1.PubMedCrossRefGoogle Scholar
  45. Basombrío, M. A., and Prehn, R. T., 1972b, Studies on the basis for diversity and time of appearance of antigens in chemically induced tumors, Natl. Cancer Inst. Monogr. 35:117.PubMedGoogle Scholar
  46. Basombrio, M. A., and Prehn, R. T., 1972c, Search for common antigenicities between embryonic and tumoral tissue, Medicina (Arg.) 32:42.Google Scholar
  47. Becker, F. F., and Sell, S., 1974, Early elevation of α 1-fetoprotein in N-2-fluorenyl-acetamide hepatocarcinogenesis, Cancer Res. 34:2489.PubMedGoogle Scholar
  48. Belehradek, J., Barski, G., and Thonier, M., 1972, Evolution of cell-mediated antitumor immunity in mice bearing a syngeneic chemically induced tumor: Influence of tumor growth, surgical removal and treatment with irradiated tumor cells, Int. J. Cancer 9:461.PubMedCrossRefGoogle Scholar
  49. Bloom, B. R., Bennett, B., Oettgen, H. F., McLean, E. P., and Old, L. J., 1969, Demonstration of delayed hypersensitivity to soluble antigens of chemically induced tumors by inhibition of macrophage migration, Proc. Natl. Acad. Sci. U.S.A. 64:1176.PubMedCrossRefGoogle Scholar
  50. Bloom, E. T., 1970, Quantitative detection of cytotoxic antibodies against tumor-specific antigens of murine sarcomas induced by 3-methylcholanthrene, J. Natl. Cancer Inst. 45:443.PubMedGoogle Scholar
  51. Bloom, E. T., and Hildemann, W. H., 1970, Mechanisms of tumor-specific enhancement versus resistance toward a methylcholanthrene-induced murine sarcoma, Transplantation 10:321.PubMedCrossRefGoogle Scholar
  52. Borberg, H., Oettgen, H. F., Choudry, K., and Beattie, E. J., 1972, Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors, Int. J. Cancer 10:539.PubMedCrossRefGoogle Scholar
  53. Bowen, J. G., Robins, R. A., and Baldwin, R. W., 1975, Serum factors modifying cell mediated immunity to rat hepatoma D23 correlated with tumour status, Int. J. Cancer 15:640.PubMedCrossRefGoogle Scholar
  54. Brawn, R. J., 1970, Possible association of embryonal antigen(s) with several primary 3-methylcholanthrene-induced murine sarcomas, Int. J. Cancer 6:245.PubMedCrossRefGoogle Scholar
  55. Buberík, J., Perlmann, P., Helmstein, K., and Moberger, G., 1970, Immune response to urinary bladder tumours in man, Int. J. Cancer 5:39.CrossRefGoogle Scholar
  56. Burdick, J. F., Cohen, A. M., and Wells, S. A., 1973, A simplified isotopic anti-globulin assay: Detection of tumor cell antigens, J. Natl. Cancer Inst. 50:285.PubMedGoogle Scholar
  57. Burnet, F. M., 1970, A certain symmetry: Histocompatibility antigens compared with immunocyte receptors, Nature (London) 226:123.CrossRefGoogle Scholar
  58. Cerottini, J. C., and Brunner, K. T., 1974, Cell-mediated cytotoxicity, allograft rejection, and tumor immunity, Advan. Immunol. 18:67.CrossRefGoogle Scholar
  59. Churchill, W. H., Zbar, B., Belli, J. A., and David, J. R., 1972, Detection of cellular immunity to tumor antigens of a guinea pig hepatoma by inhibition of macrophage migration, J. Natl. Cancer Inst. 48:541.PubMedGoogle Scholar
  60. Coggin, J. H., and Ambrose, K. R., 1969, A rapid in vivo assay for SV40 tumor immunity in hamsters, Proc, Soc. Exp. Biol. Med. 130:246.Google Scholar
  61. Coggin, J. H., Ambrose, K. R., and Anderson, N. G., 1970, Fetal antigen capable of inducing transplantation immunity against SV40 hamster tumor cells, J. Immunol. 105:524.PubMedGoogle Scholar
  62. Coggin, J. H., Ambrose, K. R., Bellomy, B. B., and Anderson, N. G., 1971, Tumor immunity in hamsters immunized with fetal tissues, J. Immunol. 107:526.PubMedGoogle Scholar
  63. Colnaghi, M. I., Ménard, S., and Delia Porta, G., 1971, Demonstration of cellular immunity against urethan-induced lung adenomas of mice, J. Natl. Cancer Inst. 47: 1325.PubMedGoogle Scholar
  64. Currie, G. A., and Alexander, P., 1974, Spontaneous shedding of TSTA by viable sarcoma cells: Its possible role in facilitating metastatic spread, Br. J. Cancer 29:72.PubMedCrossRefGoogle Scholar
  65. Currie, G. A., and Bagshawe, K. D., 1967, The masking of antigens on trophoblast and cancer cells, Lancet i:708.CrossRefGoogle Scholar
  66. Currie, G. A., and Bagshawe, K. D., 1969, Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase, Br. J. Cancer 23:141.PubMedCrossRefGoogle Scholar
  67. Delorme, E. J., and Alexander, P., 1964, Treatment of primary fibrosarcoma in the rat with immune lymphocytes, Lancet i:117.CrossRefGoogle Scholar
  68. De Vries, J. E., Rümke, P., and Bernheim, J. L., 1972, Cytotoxic lymphocytes in melanoma patients, Int. J. Cancer 9:567.CrossRefGoogle Scholar
  69. Duff, R., and Rapp, E., 1970, Reactions of serum from pregnant hamsters with surface of cells transformed by SV40, J. Immunol. 105:521.PubMedGoogle Scholar
  70. Embieton, M. J., and Heidelberger, C., 1972, Antigenicity of clones of mouse prostate cells transformed in vitro, Int. J. Cancer 9:8.CrossRefGoogle Scholar
  71. Foley, E. J., 1953, Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin, Cancer Res. 13:835.PubMedGoogle Scholar
  72. Fossati, G., Canevari, S., Delia Porta, G., Balzarini, G. P., and Veronesi, U., 1972, Cellular immunity to human breast carcinoma, Int. J. Cancer 10:391.PubMedCrossRefGoogle Scholar
  73. Globerson, A., and Feldman, M., 1964, Antigenic specificity of benzo[α]pyrene-induced sarcomas, J. Natl. Cancer Inst. 32:1229.PubMedGoogle Scholar
  74. Gordon, J., 1965, Isoantigenicity of liver tumours induced by an azo dye, Br. J. Cancer 19:387.PubMedCrossRefGoogle Scholar
  75. Graffi, A., Pasternak, G., and Horn, K.-H., 1964, Die Erzeugung von Resistenz gegen isologe Transplantate UV-induzierter Sarkome der Maus, Acta Biol. Med. Ger. 12:725.Google Scholar
  76. Graffi, A., Pasternak, G., and Hölzer, B., 1965, Erzeugung von Transplantationresistenz gegen ein syngenes UV-Sarkom durch Vorbehandlung von Mäusen mit Mitochon-drienpräparationen des gleichen Tumors, Arch. Geschwulstforsch. 26:114.PubMedGoogle Scholar
  77. Halliday, W. J., 1971, Blocking effect of serum from tumor-bearing animals on macrophage migration inhibition with tumor antigens, J. Immunol. 106:855.PubMedGoogle Scholar
  78. Halliday, W. J., and Webb, M., 1969, Delayed hypersensitivity to chemically-induced tumors in mice and correlation with an in vitro test, J. Natl. Cancer Inst. 43:141.PubMedGoogle Scholar
  79. Harder, F. H., and McKhann, C. F., 1968, Demonstration of cellular antigens on sarcoma cells by an indirect 125I-labeled antibody technique, J. Natl. Cancer Inst. 40:231.PubMedGoogle Scholar
  80. Heidelberger, C., 1973, Chemical oncogenesis in culture, Advan. Cancer Res. 18:317.CrossRefGoogle Scholar
  81. Hellström, I., and Hellström, K. E., 1969, Studies on cellular immunity and its serum-mediated inhibition in Moloney-virus-induced mouse sarcomas, Int. J. Cancer 4:587.PubMedCrossRefGoogle Scholar
  82. Hellström, I., and Hellström, K. E., 1975a, Cytotoxic effect of lymphocytes from pregnant mice on cultivated tumor cells. I. Specificity, nature of effector cells, blocking by serum, Int. J. Cancer 15:1.PubMedCrossRefGoogle Scholar
  83. Hellström, I., and Hellström, K. E., 1975b, Cytotoxic effect of lymphocytes from multiparous mice on cultivated tumor cells. II. Blocking and unblocking of cytotoxicity, Int. J. Cancer 15:30.PubMedCrossRefGoogle Scholar
  84. Hellström, I., Hellström, K. E., and Pierce, G. E., 1968, In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methyl-cholanthrene and plastic discs, Int. J. Cancer 3:467.PubMedCrossRefGoogle Scholar
  85. Hellström, I., Hellström, K. E., and Sjögren, H. O., 1970, Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas, Cell. Immunol. 1:18.PubMedCrossRefGoogle Scholar
  86. Hellström, I., Hellström, K. E., Sjögren, H. O., and Warner, G. A., 1971a, Demonstration of cell-mediated immunity to human neoplasms of various histological types, Int. J. Cancer 7:1.PubMedCrossRefGoogle Scholar
  87. Hellström, I., Hellström, K. E., Sjögren, H. O., and Warner, G. A., 1971b, Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity, Int. J. Cancer 8:185.PubMedCrossRefGoogle Scholar
  88. Hellström, K. E., and Hellström, I., 1969, Cellular immunity against tumor antigens, Advan. Cancer Res. 12:167.CrossRefGoogle Scholar
  89. Hellström, K. E., and Hellström, I., 1970, Immunological enhancement as studied by cell culture techniques, Annu: Rev. Microbiol. 24:373.CrossRefGoogle Scholar
  90. Hellström, K. E., and Hellström, I., 1974, Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens, Advan. Immunol. 18:209.CrossRefGoogle Scholar
  91. Herberman, R. B., Ting, C. C., Kirchner, H., Holden, H., Glaser, M., Bonnard, G. D., and Lavrin, D., 1974, Effector mechanisms in tumor immunity, in: Progress in Immunology II Vol. 3 (L. Brent and J. Holborow, eds.), pp. 285–295, North-Holland, Amsterdam.Google Scholar
  92. Holmes, E. C., Kahan, B. D., and Morton, D. L., 1970, Soluble tumor-specific transplantation antigens from methylcholanthrene-induced guinea pig sarcomas, Cancer 25:373.PubMedCrossRefGoogle Scholar
  93. Holmes, E. C., Morton, D. L., Schidlovsky, G., and Trahan, E., 1971, Cross-reacting tumor-specific transplantation antigens in methylcholanthrene-induced guinea pig sarcomas, J. Natl. Cancer Inst. 46:693.PubMedGoogle Scholar
  94. Hopper, D. G., Pimm, M. V., and Baldwin, R. W., 1975, Methanol extraction residue of BCG in the treatment of transplanted rat tumours, Br. J. Cancer 31:176.PubMedCrossRefGoogle Scholar
  95. Horn, K.-H., Pasternak, G., and Graffi, A., 1965, Versuche zur Erzeugung tumorspezifischer Resistenz gegen isolog transplantable Sarkome, die durch Implantation von Kunststoffen erzeugt wurden, Acta Biol. Med. Ger. 15:154.Google Scholar
  96. Hull, E. W., Carbone, R. P., Gitlin, D., O’Gara, R. W., and Kelly, M. G., 1969, α-Fetoprotein in monkeys with hepatoma, J. Natl. Cancer Inst. 42:1035.PubMedGoogle Scholar
  97. Ishidate, M., 1967, Recognition of the individuality of tumour strain by sensitized peritoneal lymphoid cells, Nature (London) 215:184.CrossRefGoogle Scholar
  98. Ishidate, M., 1970, Antigenic specificity of hepatoma cell lines derived from a single rat, in: Abstracts, International Cancer Congress, Houston, p. 227.Google Scholar
  99. Johnson, S., 1968, The effect of thymectomy and of the dose of 3-methylcholanthrene on the induction and antigenic properties of sarcomas in C57 BL mice, Br. J. Cancer 22:93.PubMedCrossRefGoogle Scholar
  100. Kim, U., 1970, Metastasizing mammary carcinomas in rats: Induction and study of their immunogenicity, Science 167: 72.PubMedCrossRefGoogle Scholar
  101. Kitagawa, T., Yokochi, T., and Sugano, H., 1972, α-Fetoprotein and hepatocarcinogene-sis in rats fed 3′-methyl-4-(dimethylamino)azo-benzene or N-2-fluorenylacetamide, Int. J. Cancer 10:368.PubMedCrossRefGoogle Scholar
  102. Klein, G., 1966, Tumor antigens, Annu. Rev. Microbiol. 20:223.PubMedCrossRefGoogle Scholar
  103. Klein, G., Sjögren, H. O., Klein, E., and Hellström, K. E., 1960, Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host, Cancer Res. 20:1561.PubMedGoogle Scholar
  104. Klein, G., Sjögren, H. O., and Klein, E., 1963, Demonstration of host resistance against sarcomas induced by implantation of cellophane films in isologous (syngeneic) recipients, Cancer Res. 23:84.PubMedGoogle Scholar
  105. Kroes, R., Williams, G. M., and Weisburger, J. H., 1972, Early appearance of serum α-fetoprotein during hepatocarcinogenesis as a function of age of rats and extent of treatment with 3′-methyl-4-dimethylaminoazobenzene, Cancer Res. 32:1526.PubMedGoogle Scholar
  106. Kronman, B. S., Rapp, H. J., and Borsos, T., 1969, Tumor-specific antigens: Detection by local transfer of delayed skin hypersensitivity, J. Natl. Cancer Inst. 43:869.PubMedGoogle Scholar
  107. Lappé, M. A., 1968, Evidence for the antigenicity of papillomas induced by 3-methylcholanthrene, J. Natl. Cancer Inst. 40:823.PubMedGoogle Scholar
  108. Lappé, M. A., 1969, Tumour specific transplantation antigens: Possible origin in premalignant lesions, Nature (London) 223:82.CrossRefGoogle Scholar
  109. Lejneva, O. M., Zilber, L. A., and levleva, E. S., 1965, Humoral antibodies to methylcholanthrene sarcomata detected by a fluorescent technique, Nature (London) 206:1163.CrossRefGoogle Scholar
  110. Leonard, E. J., Meltzer, M. S., Borsos, T., and Rapp, H. J., 1972, Properties of tumor-specific antigen solubilized by hypertonic potassium chloride, Natl. Cancer Inst. Monogr. 35:129.PubMedGoogle Scholar
  111. Lespinats, G., 1969, Induction d’une immunité vis-à-vis de la greffe de plasmocytosar-comes chez la souris BALB/c, Eur. J. Cancer 5:421.PubMedGoogle Scholar
  112. Lespinats, G., 1970, Tumor-specific humoral antibodies against plasma cell tumors in immunized BALB/c mice, J. Natl. Cancer Inst. 45:845.PubMedGoogle Scholar
  113. Mann, D. L., Fahey, J. L., and Nathenson, S. G., 1970, Molecular comparisons of papain solubilized H-2 and HL-A alloantigens, in: Histocompatibility Testing, 1970 (P. I. Terasaki, ed.), pp. 461–466, Munksgaard, Copenhagen.Google Scholar
  114. Mathé, G., 1967, Antigénicité nouvelle démontrée par isogreffe d’un fragment de peau prélevé 5 jours après injection intradermique de di-methyl-benzenthracène, Rev. Fr. Etud. Clin. Biol. 12:380.PubMedGoogle Scholar
  115. McCollester, D. L., 1970, Isolation of Meth A cell surface membranes possessing tumor-specific transplantation antigen activity, Cancer Res. 30:2832.PubMedGoogle Scholar
  116. Meltzer, M. S., Leonard, E. J., Rapp, H. J., and Borsos, T., 1971, Tumor-specific antigen solubilized by hypertonic potassium chloride, J. Natl. Cancer Inst. 47:703.PubMedGoogle Scholar
  117. Meltzer, M. S., Oppenheim, J. J., Littman, B. H., Leonard, E. J., and Rapp, H. J., 1972, Cell-mediated tumor immunity measured in vitro and in vivo with soluble tumor specific antigens, J. Natl. Cancer Inst. 49:727.PubMedGoogle Scholar
  118. Mondai, S., Iype, P. T., Griesbach, L. M., and Heidelberger, C., 1970, Antigenicity of cells derived from mouse prostate after malignant transformation in vitro by carcinogenic hydrocarbons, Cancer Res. 30:1593.Google Scholar
  119. Mondai, S., Embleton, M. J., Marquardt, H., and Heidelberger, C., 1971, Production of variants of decreased malignancy and antigenicity from clones transformed in vitro by methylcholanthrene, Int. J. Cancer 8:410.Google Scholar
  120. Moore, M., and Williams, D. E., 1972, Studies on the antigenicity of radiation-induced murine osteosarcomata, Br. J. Cancer 26:90.PubMedCrossRefGoogle Scholar
  121. Morton, D. L., Goldman, L., and Wood, D., 1965, Tumor specific antigenicity of methylcholanthrene (MCA) and dibenzanthracene (DBA) induced sarcomas of inbred guinea pigs, Fed. Proc. 24:684.Google Scholar
  122. Müller, M., 1968, Versuche zur Erzeugung einer Transplantationsimmunität gegen o-Aminoazotoluol-Hepatome bei syngenen und F1-Hybrid-Mäusen, Arch. Geschwulstforsch. 31:235.PubMedGoogle Scholar
  123. Muramatsu, T., and Nathenson, S. G., 1971, Carbohydrate structure of mouse H-2 alloantigens, Fed. Proc. 30:691 Abs.Google Scholar
  124. Oettgen, H. F., Old, L. J., McLean, E. P., and Carswell, E. A., 1968, Delayed hypsersensitivity and transplantation immunity elicited by soluble antigens of chemically induced tumours in inbred guinea pigs, Nature (London) 220:295.CrossRefGoogle Scholar
  125. Old, L. J., Boyse, E. A., Clarke, D. A., and Carswell, E. A., 1962, Antigenic properties of chemically induced tumors, Ann. N.Y. Acad. Sci. 101:80.CrossRefGoogle Scholar
  126. Old, L. J., Boyse, E. A., and Stockert, E., 1963, Antigenic properties of experimental leukemias. I. Serological studies in vitro with spontaneous and radiation-induced leukemias, J. Natl. Cancer Inst. 31:977.PubMedGoogle Scholar
  127. Oppenheim, J. J., Zbar, B., and Rapp, H. J., 1970, Specific inhibition of tumor cell DNA synthesis in vitro by lymphocytes from peritoneal exudate of immunized syngeneic guinea pigs, Proc. Natl. Acad. Sci. U.S.A. 66:1119.PubMedCrossRefGoogle Scholar
  128. O’Toole, C., Perlmann, P., Unsgaard, B., Moberger, G., and Edsmyr, F., 1972a, Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy, Int. J. Cancer 10:77.PubMedCrossRefGoogle Scholar
  129. O’Toole, C., Perlmann, P., Unsgaard, B., Almgard, L. E., Johansson, B., Moberger, G., and Edsmyr, F., 1972b, Cellular immunity to urinary bladder carcinoma. II. Effect of surgery and pre-operative irradiation, Int. J. Cancer 10:92.PubMedCrossRefGoogle Scholar
  130. Ozer, J. H., and Wallach, D. F. H., 1967, H-2 components and cellular membranes: Distinctions between plasma membrane and endoplasmic reticulum governed by the H-2 region in the mouse, Transplantation 5:652.PubMedCrossRefGoogle Scholar
  131. Pasternak, G., 1963, Die unterschiedliche Reaktionsfähigkeit zweier Mäuseinzucht-stämme gegen spezifische Antigene isolog transplantabler Carcinogentumoren, Acta Biol. Med. Ger. 10:572.PubMedGoogle Scholar
  132. Pasternak, G., Graffi. A., Hoffmann, F., and Horn K.-H., 1964, Resistance against carcinomas of the skin induced by dimethylbenzanthracene (DMBA) in mice of the strain XVIVBln, Nature (London) 203:307.CrossRefGoogle Scholar
  133. Pasternak, G., Hoffmann, F., and Graffi, A., 1966, Growth of diethylnitrosamine-induced lung tumours in syngeneic mice specifically pre-treated with X-ray killed tumour tissue, Folia Biol. (Praha) 12:299.Google Scholar
  134. Pilch, Y. H., 1968, The antigenicity and immunogenicity of cell-free extracts of chemically induced murine sarcomas, Cancer Res. 28:2502.PubMedGoogle Scholar
  135. Plata, F., and Levy, J. P., 1974, Blocking of syngeneic effector T cells by soluble tumour antigens, Nature (London) 249:271.CrossRefGoogle Scholar
  136. Poupon, M.-F., and Lespinats, G., 1972, Cell-mediated immunity directed against a syngeneic plasma cell tumor in the mouse: Detection by macrophage migration inhibition test, J. Natl. Cancer Inst. 48:1297.PubMedGoogle Scholar
  137. Prehn, R. T., 1960, Tumor-specific immunity to transplanted dibenz[a,h]anthracene-induced sarcomas, Cancer Res. 20:1614.Google Scholar
  138. Prehn, R. T., 1962, Specific isoantigenicities among chemically induced tumors, Ann. N.Y.Acad. Sci. 101:107.CrossRefGoogle Scholar
  139. Prehn, R. T., 1963, Role of immune mechanisms in the biology of chemically and physically induced tumors, in: Conceptual Advances in Immunology and Oncology, pp. 475–485, Harper and Row, New York.Google Scholar
  140. Prehn, R. T., and Main, J. M., 1957, Immunity to methylcholanthrene-induced sarcomas, J. Natl. Cancer Inst. 18:769.PubMedGoogle Scholar
  141. Price, M. R., and Baldwin, R. W., 1974a, Preparation of aminoazo dye-induced rat hepatoma membrane fractions retaining tumour specific antigen, Br. J. Cancer 30:382.PubMedCrossRefGoogle Scholar
  142. Price, M. R., and Baldwin, R. W., 1974b, Immunogenic properties of rat hepatoma subcellular fractions, Br. J. Cancer 30:394.PubMedCrossRefGoogle Scholar
  143. Rapaport, F. T., Dausset, J., Converse, J. M., and Lawrence, H. S., 1965, Biological and ultrastructural studies of leucocyte fractions as transplantation antigens in man, Transplantation 3:490.PubMedCrossRefGoogle Scholar
  144. Reiner, J., and Southam, C. M., 1967, Evidence of common antigenic properties in chemically induced sarcomas of mice, Cancer Res. 27:1243.PubMedGoogle Scholar
  145. Reiner, J., and Southam, C. M., 1969, Further evidence of common antigenic properties in chemically induced sarcomas of mice, Cancer Res. 29:1814.PubMedGoogle Scholar
  146. Reisfeld, R. A., and Kahan, B. D., 1970a, Biological and chemical characterization of human histocompatibility antigens, Fed. Proc. 29:2034.PubMedGoogle Scholar
  147. Reisfeld, R. A., and Kahan, B. D., 1970b, Transplantation antigens, Advan. Immunol. 12:117.CrossRefGoogle Scholar
  148. Reisfeld, R. A., and Kahan, B. D., 1972, Markers of biological individuality, Sci. Am. 226(6):28.PubMedCrossRefGoogle Scholar
  149. Reisfeld, R. A., Pellegrino, M. A., and Kahan, B. D., 1971, Salt extraction of soluble HL-A antigens, Science 172:1134.PubMedCrossRefGoogle Scholar
  150. Révész, L., 1960, Detection of antigenic differences in isologous host-tumor systems by pretreatment with heavily irradiated tumor cells, Cancer Res. 20:443.Google Scholar
  151. Robins, R. A., and Baldwin, R. W., 1974, Tumour specific antibody neutralization of factors in rat hepatoma bearer serum which abrogate lymph node cell cytotoxicity, Int. J. Cancer 14:589.PubMedCrossRefGoogle Scholar
  152. Rosenau, W., and Morton, D. L., 1966, Tumor-specific inhibition of growth of methylcholanthrene-induced sarcomas in vivo and in vitro by sensitized isologous lymphoid cells, J. Natl. Cancer Inst. 36:825.Google Scholar
  153. Ruoslahti, E., Pihko, H., and Seppälä, M., 1974, Alpha-fetoprotein: Immunochemical purification and chemical properties. Expression in normal state and in malignant and non-malignant liver disease, Transplant. Rev. 20:38.PubMedGoogle Scholar
  154. Sanderson, C. J., and Frost, P., 1974, The induction of tumour immunity in mice using glutaraldehyde-treated tumour cells, Nature (London) 248:690.CrossRefGoogle Scholar
  155. Shellam, G. R., and Knight, R. A., 1974, Antigenic inhibition of cell-mediated cytotoxicity against tumour cells, Nature (London) 252:330.CrossRefGoogle Scholar
  156. Simmons, R. L., and Rios, A., 1974, Cell surface modification in the treatment of xperimental cancer: Neuraminidase or concanavalin A, Cancer 34:1541.PubMedCrossRefGoogle Scholar
  157. Simmons, R. L., Rios, A., Ray, P. K., and Lundgren, G., 1971, Effect of neuraminidase on growth of a 3-methylcholanthrene-induced fibrosarcoma in normal and immuno-suppressed syngeneic mice, J. Natl. Cancer Inst. 47:1087.PubMedGoogle Scholar
  158. Sjögren, H. O., Hellström, I., Bansal, S. C., and Hellström, K. E., 1971, Suggestive evidence that the “blocking antibodies” of tumor-bearing individuals may be antigen-antibody complexes, Proc. Natl. Acad. Sci. U.S.A. 68:1372.PubMedCrossRefGoogle Scholar
  159. Sjögren, H. O., Hellström, I., Bansal, S. C., Warner, G. A., and Hellström, K. E., 1972, Elution of “blocking factors” from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes, Int. J. Cancer 9:274.PubMedCrossRefGoogle Scholar
  160. Stanislawski-Birencwajg, M., Uriel, J., and Grabar, P., 1967, Association of embryonic antigens with experimentally-induced hepatic lesions in the rat, Cancer Res. 27:1990.PubMedGoogle Scholar
  161. Steele, G., and Sjögren, H. O., 1974, Embryonic antigens associated with chemically induced colon carcinomas in rats, Int. J. Cancer 14:435.PubMedCrossRefGoogle Scholar
  162. Stutman, O., 1972, Immunological studies on resistance to oncogenic agerts in mice, Natl. Cancer Inst. Monogr. 35:107.PubMedGoogle Scholar
  163. Suter, L., Bloom, B. R., Wadsworth, E. M., and Oettgen, H. F., 1972, Use of the macrophage migration inhibition test to monitor fractionation of soluble antigens of chemically induced sarcomas of inbred guinea pigs, J. Immunol. 109:766.PubMedGoogle Scholar
  164. Takasugi, M., and Klein, E., 1970, A microassay for cell-mediated immunity, Transplantation 9:219.PubMedCrossRefGoogle Scholar
  165. Takeda, K., 1969, Immunology of Cancer, Hokkaido University, Sapporo, Japan.Google Scholar
  166. Takeda, K., Aizawa, M., Kituchi, Y., Yamawaki, S., and Nakamura, K., 1966, Tumour autoimmunity against methylcholanthrene-induced sarcomas of the rat, Gann 57:221.PubMedGoogle Scholar
  167. Taranger, L. A., Chapman, W. H., Hellström, I., and Hellström, K. E., 1972a, Immunological studies on urinary bladder tumors of rats and mice, Science 176:1337.PubMedCrossRefGoogle Scholar
  168. Taranger, L. A., Hellström, I., Chapman, W. H., and Hellström, K. E., 1972b, In vitro demonstration of common tumor antigens in mouse and rat bladder carcinomas, Proc. Am. Assoc. Cancer Res. 13:56.Google Scholar
  169. Thomson, D. M. P., and Alexander, P., 1973, A cross-reacting embryonic antigen in the membrane of rat sarcoma cells which is immunogenic in the syngeneic host, Br. J. Cancer 27:35.PubMedCrossRefGoogle Scholar
  170. Thomson, D. M. P., Eccles, S., and Alexander, P., 1973a, Antibodies and soluble tumour-specific antigens in blood and lymph of rats with chemically induced sarcomata, Br. J. Cancer 28:6.PubMedCrossRefGoogle Scholar
  171. Thomson, D. M. P., Sellens, V., Eccles, S., and Alexander, P., 1973b, Radioimmunoassay of tumour-specific transplantation antigen of a chemically-induced rat sarcoma: Circulating soluble antigen in tumour bearers, Br. J. Cancer 28:377.PubMedCrossRefGoogle Scholar
  172. Tuffrey, M. A., and Batchelor, J. R., 1964, Tumour specific immunity against murine epitheliomas induced with 9,10-dimethyl-l,2-benzanthracene, Nature (London) 204:349.CrossRefGoogle Scholar
  173. Vaage, J., 1971, Concomitant immunity and specific depression of immunity by residual or reinjected tumor tissue, Cancer Res. 31:1655.PubMedGoogle Scholar
  174. Vaage, J., 1972, Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice, Cancer Res. 32:193.PubMedGoogle Scholar
  175. Vaage, J., 1974, Circulating tumor antigens versus immune serum factors in depressed concomitant immunity, Cancer Res. 34:2979.PubMedGoogle Scholar
  176. Vaage, J., Jones, R. D., and Brown, B. W., 1972, Tumor-specific resistance in mice detected by inhibition of macrophage migration, Cancer Res. 32:680.PubMedGoogle Scholar
  177. Wahl, D. V., Chapman, I., Hellström, I., and Hellström, K. E., 1974, Transplantation immunity to individually unique antigens of chemically induced bladder tumors in mice, Int. J. Cancer 14:114.PubMedCrossRefGoogle Scholar
  178. Watabe, H., Hirai, H., and Satoh, H., 1972, α-Fetoprotein in rats transplanted with ascites hepatoma, Gann 63:189.PubMedGoogle Scholar
  179. Wepsic, H. T., Zbar, B., Rapp, H. J., and Borsos, T., 1970, Systemic transfer of tumor immunity: Delayed hypersensitivity and suppression of tumor growth, J. Natl. Cancer Inst. 44:955.PubMedGoogle Scholar
  180. Wolf, A., and Avis, P. J. G., 1970, Preparation and purification of plasma membranes from murine lymphoma cells carrying tumour-specific antigenicity, Transplantation 9:18.PubMedCrossRefGoogle Scholar
  181. Zbar, B., Wepsic, H. T., Rapp, H. J., Borsos, T., Kronman, B. S., and Churchill, W. H., 1969, Antigenic specificity of hepatomas induced in strain 2 guinea pigs by diethylnitrosamine, J. Natl. Cancer Inst. 43:833.PubMedGoogle Scholar
  182. Zbar, B., Wepsic, H. T., Rapp, H. J., Stewart, L. C., and Borsos, T., 1970, Two-step mechanism of tumor graft rejection in syngeneic guinea pigs. II. Initiation of reaction by a cell fraction containing lymphocytes and neutrophils, J. Natl. Cancer Inst. 44:701.PubMedGoogle Scholar
  183. Zbar, B., Bernstein, I. D., and Rapp, H. J., 1971, Suppression of tumor growth at the site of infection with living bacillus Calmette Guérin, J. Natl. Cancer Inst. 46:831.PubMedGoogle Scholar
  184. Zbar, B., Bernstein, I. D., Bartlett, G. L., Hanna, G., and Rapp, H. J., 1972a, Immunotherapy of cancer: Regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis, J. Natl. Cancer Inst. 49:119.PubMedGoogle Scholar
  185. Zbar, B., Rapp, H. J., and Ribi, E. E., 1972b, Tumor suppression by cell walls of Mycobacterium bovis attached to oil droplets, J. Natl. Cancer Inst. 48:831.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • Robert W. Baldwin
    • 1
  • Michael R. Price
    • 1
  1. 1.Cancer Research Campaign LaboratoriesUniversity of NottinghamNottinghamEngland

Personalised recommendations